Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Expanding Treatment Options for Metastatic Breast Cancer
EP. 1: Treatment After Progression on CDK 4/6i in mBC
April 22nd 2020
EP. 2: SOLAR-1 Trial in Metastatic Breast Cancer
April 22nd 2020
EP. 3: Payer Perspective of Coverage on Cancer Therapies
April 22nd 2020
EP. 4: Payer Coverage on Repeat Biopsy in mBC
April 22nd 2020
EP. 5: Advantages of Oral Taxanes in mBC
April 22nd 2020
EP. 6: Compliance and Adherence to Therapy in mBC
April 22nd 2020
EP. 7: Payer Coverage of IV Versus Oral Therapy in mBC
April 22nd 2020
EP. 8: Evolving Treatment Landscape of R/R HER2+ mBC
April 22nd 2020
EP. 9: HER2CLIMB and NALA Trials: R/R HER2+ mBC
April 22nd 2020
EP. 10: SOPHIA Trial in R/R HER2+ mBC
April 22nd 2020
EP. 11: Sequencing of Therapy in R/R HER2+ mBC
April 22nd 2020
EP. 12: IMpassion130 Trial Data on PD-L1+ Tumors in TNBC
April 22nd 2020
EP. 13: Role of PARP Inhibition and I/O Therapy in TNBC
April 22nd 2020
EP. 14: Treatment Options in Metastatic TNBC
April 22nd 2020
EP. 15: Considerations for NGS Testing in mTNBC
April 22nd 2020
EP. 16: Assessing the Value of Personalized Treatment in mBC
April 22nd 2020
EP. 17: Closing Thoughts on Metastatic Breast Cancers
April 22nd 2020